The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
High Affinity Binding and Overlapping Localization of Neurocan and Phosphacan/Protein-tyrosine Phosphatase-ζ/β with Tenascin-R, Amphoterin, and the Heparin-binding Growth-associated Molecule
Open accessAbstract
We have studied the interactions of the nervous tissue-specific chondroitin sulfate proteoglycans neurocan and phosphacan with the extracellular matrix protein tenascin-R and two heparin-binding proteins, amphoterin and the heparin-binding growth-associated molecule (HB-GAM), using a radioligand binding assay. Both proteoglycans show saturable, high affinity binding to tenascin-R with apparent dissociation constants in the 2-7 nM range. Binding is reversible, inhibited in the presence of unlabeled proteoglycan, and increased by approximately 60% following chondroitinase treatment of the proteoglycans, indicating that the interactions are mediated via the core (glyco)proteins rather than by the glycosaminoglycan chains, which may in fact partially shield the binding sites. In contrast to their interactions with tenascin-C, in which binding was decreased by approximately 75% in the absence of calcium, binding of phosphacan to tenascin-R was not affected by the absence of divalent cations in the binding buffer, although there was a small but significant decrease in the binding of neurocan. Neurocan and phosphacan are also high affinity ligands of amphoterin and HB-GAM (Kd = 0.3-8 nM), two heparin-binding proteins that are developmentally regulated in brain and functionally involved in neurite outgrowth. The chondroitin sulfate chains on neurocan and phosphacan account for at least 80% of their binding to amphoterin and HB-GAM. The presence of amphoterin also produces a 5-fold increase in phosphacan binding to the neural cell adhesion molecule contactin. Immunocytochemical studies showed an overlapping localization of the proteoglycans and their ligands in the embryonic and postnatal brain, retina, and spinal cord. These studies have therefore revealed differences in the interactions of neurocan and phosphacan with the two major members of the tenascin family of extracellular matrix proteins, and also suggest that chondroitin sulfate proteoglycans play an important role in the binding and/or presentation of differentiation factors in the developing central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Algorithm for Least-Squares Estimation of Nonlinear Parameters
Marquardt, D. W. (1963) · Journal of the Society for Industrial and Applied Mathematics · doi:10.1137/0111030 · Cited by 30,728
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Research works printed but not linked: 38
- Grumet, 1994, J. Biol. Chem., 269, 12142, 10.1016/S0021-9258(17)32692-3 · DOI · Paper page
- Milev, 1997, J. Biol. Chem., 272, 15501, 10.1074/jbc.272.24.15501 · DOI
- Friedlander, 1994, J. Cell Biol., 125, 669, 10.1083/jcb.125.3.669 · DOI · Paper page
- Milev, 1994, J. Cell Biol., 127, 1703, 10.1083/jcb.127.6.1703 · DOI · Paper page
- Milev, 1996, J. Biol. Chem., 271, 15716, 10.1074/jbc.271.26.15716 · DOI · Paper page
- Engel, 1996, J. Comp. Neurol., 366, 34, 10.1002/(SICI)1096-9861(19960226)366:1<34::AID-CNE3>3.0.CO;2-L · DOI
- Maurel, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 2512, 10.1073/pnas.91.7.2512 · DOI · Paper page
- Shitara, 1994, J. Biol. Chem., 269, 20189, 10.1016/S0021-9258(17)32144-0 · DOI
- Maeda, 1994, FEBS Lett., 354, 67, 10.1016/0014-5793(94)01093-5 · DOI
- Milev, 1995, J. Biol. Chem., 270, 24650, 10.1074/jbc.270.42.24650 · DOI
- Margolis, 1996, Perspect. Dev. Neurobiol., 3, 273
- Aspberg, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 10590, 10.1073/pnas.92.23.10590 · DOI
- Schachner, 1994, Perspect. Dev. Neurobiol., 2, 33
- Faissner, 1995, Glia, 13, 233, 10.1002/glia.440130402 · DOI · Paper page
- Nörenberg, 1996, Int. J. Dev. Neurosci., 14, 217, 10.1016/0736-5748(96)00009-3 · DOI
- Maeda, 1996, J. Biol. Chem., 271, 21446, 10.1074/jbc.271.35.21446 · DOI · Paper page
- Rauvala, 1989, EMBO J., 8, 2933, 10.1002/j.1460-2075.1989.tb08443.x · DOI · Paper page
- Merenmies, 1990, J. Biol. Chem., 265, 16721, 10.1016/S0021-9258(17)44817-4 · DOI · Paper page
- Raulo, 1992, J. Biol. Chem., 267, 11408, 10.1016/S0021-9258(19)49925-0 · DOI
- Rauvala, 1997, Prog. Neurobiol., 52, 127, 10.1016/S0301-0082(97)00007-5 · DOI
- Merenmies, 1991, J. Biol. Chem., 266, 16722, 10.1016/S0021-9258(18)55361-8 · DOI · Paper page
- Parkkinen, 1993, J. Biol. Chem., 268, 19726, 10.1016/S0021-9258(19)36575-5 · DOI · Paper page
- Nair, 1997, J. Neurochem., 68, 1286, 10.1046/j.1471-4159.1997.68031286.x · doi:10.1046/j.1471-4159.1997.68031286.x
- Rauch, 1991, J. Biol. Chem., 266, 14785, 10.1016/S0021-9258(18)98755-7 · DOI · Paper page
- Pesheva, 1989, J. Cell Biol., 109, 1765, 10.1083/jcb.109.4.1765 · DOI · Paper page
- Zisch, 1992, J. Cell Biol., 119, 203, 10.1083/jcb.119.1.203 · DOI
- Meyer-Puttlitz, 1996, J. Comp. Neurol., 366, 44, 10.1002/(SICI)1096-9861(19960226)366:1<44::AID-CNE4>3.0.CO;2-K · doi:10.1002/(sici)1096-9861(19960226)366:1<44::aid-cne4>3.0.co;2-k
- Morganti, 1990, Exp. Neurol., 109, 98, 10.1016/S0014-4886(05)80012-3 · DOI
- Pesheva, 1990, Eur. J. Neurosci., 3, 356, 10.1111/j.1460-9568.1991.tb00823.x · DOI
- Munson, 1980, Anal. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1 · DOI · Paper page
- Peles, 1995, Cell, 82, 251, 10.1016/0092-8674(95)90312-7 · DOI · Paper page
- Sakurai, 1997, J. Cell Biol., 136, 907, 10.1083/jcb.136.4.907 · DOI · Paper page
- Wewetzer, 1995, Brain Res., 693, 31, 10.1016/0006-8993(95)00683-H · doi:10.1016/0006-8993(95)00683-h
- Silos-Santiago, 1996, J. Neurobiol., 31, 283, 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6 · doi:10.1002/(sici)1097-4695(199611)31:3<283::aid-neu2>3.0.co;2-6
- Xiao, 1997, J. Biol. Chem., 272, 32092, 10.1074/jbc.272.51.32092 · DOI
- Rauvala, 1987, J. Biol. Chem., 262, 16625, 10.1016/S0021-9258(18)49302-7 · DOI · Paper page
- Rauch, 1997, J. Biol. Chem., 272, 26905, 10.1074/jbc.272.43.26905 · DOI
- Aspberg, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 10116, 10.1073/pnas.94.19.10116 · DOI · Paper page
Cited by
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Jones, F. S., & Jones, P. L. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200006)218:2<235::aid-dvdy2>3.0.co;2-g · Cited by 690
Lecticans: organizers of the brain extracellular matrix
Yamaguchi, Y. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000690 · Cited by 642
Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Bandtlow, C. E., & Zimmermann, D. R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1267 · Cited by 632
Huttunen, H. J., Kuja-Panula, J., Sorci, G., Agneletti, A. L., Donato, R., & Rauvala, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006993200 · Cited by 577
Self-citationGaltrey, C. M., & Fawcett, J. W. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.006 · Cited by 575
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Extracellular matrix of the central nervous system: from neglect to challenge
Zimmermann, D. R., & Dours-Zimmermann, M. T. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0485-9 · Cited by 465
“Notably, we also observed two- to threefold reductions, but never an abolition of the inhibitory capacity of versican V2 in stripe choice experiments after complete glycosaminoglycan-removal (Schmalfeldt et al. LTP Hippocampal long-term potentiation, EAE experimental autoimmune encephalomyelitis, PNN perineuronal net,…”
BackgroundInfluentialRecent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans
Sugahara, K., & Kitagawa, H. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00125-1 · Cited by 423
Meng, K., Rodríguez-Peña, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M., & Deuel, T. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.020487997 · Cited by 418
Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor
Iozzo, R. V., Moscatello, D. K., McQuillan, D. J., & Eichstetter, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4489 · Cited by 382
Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8770com · Cited by 366
Masquerader: High Mobility Group Box-1 and Cancer
Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., & Lotze, M. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1953 · Cited by 355
Härtig, W., Derouiche, A., Welt, K., Brauer, K., Grosche, J., Mäder, M., Reichenbach, A., & Brückner, G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01784-9 · Cited by 339
(2002) · PubMed · Cited by 292
Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals?
Reissner, K. J., & Aswad, D. W. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2287-5 · Cited by 282
Astrocytes as a Source for Extracellular Matrix Molecules and Cytokines
Wiese, S., Karus, M., & Faissner, A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00120 · Cited by 262
Weber, P., Bartsch, U., Rasband, M. N., Czaniera, R., Lang, Y., Bluethmann, H., Margolis, R. U., Levinson, S. R., Shrager, P., Montag, D., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04245.1999 · Cited by 247
Self-citationBukalo, O., Schachner, M., & Dityatev, A. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00082-3 · Cited by 236
Self-citationNeurocan Is Dispensable for Brain Development
Zhou, X.-H., Brakebusch, C., Matthies, H., Oohashi, T., Hirsch, E., Moser, M., Krug, M., Seidenbecher, C. I., Boeckers, T. M., Rauch, U., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5970-5978.2001 · Cited by 206
Galtrey, C. M., Kwok, J. C. F., Carulli, D., Rhodes, K. E., & Fawcett, J. W. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06108.x · Cited by 203
Brückner, G., Hausen, D., Härtig, W., Drlicek, M., Arendt, T., & Brauer, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00071-8 · Cited by 196
Dzyubenko, E., Gottschling, C., & Faissner, A. (2016) · Neural Plasticity · doi:10.1155/2016/5214961 · Cited by 134
Versican V2 Assembles the Extracellular Matrix Surrounding the Nodes of Ranvier in the CNS
Dours-Zimmermann, M. T., Maurer, K., Rauch, U., Stoffel, W., Fassler, R., & Zimmermann, D. R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4158-08.2009 · Cited by 123
Immunoregulatory properties of the cytokine IL-34
Guillonneau, C., Bézie, S., & Anegon, I. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2482-4 · Cited by 112
“PTP-ζ has other ligands, such as pleiotrophin [38], the cell surface protein contactin [39], and the extracellular matrix protein tenascin-R [40].”
BackgroundMorphology of perineuronal nets in tenascin-R and parvalbumin single and double knockout mice
Haunsø, A., Ibrahim, M., Bartsch, U., Letiembre, M., Celio, M. R., & Menoud, P.-A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02173-9 · Cited by 61
Haunsø, A., Celio, M. R., Margolis, R. K., & Menoud, P.-A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01596-6 · Cited by 52
Self-citationKähler, A. K., Djurovic, S., Rimol, L. M., Brown, A. A., Athanasiu, L., Jönsson, E. G., Hansen, T., Gústafsson, Ó., Hall, H., Giegling, I., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.035 · Cited by 48
The protein tyrosine phosphatase RPTPζ/phosphacan is critical for perineuronal net structure
Eill, G. J., Sinha, A., Morawski, M., Viapiano, M. S., & Matthews, R. T. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49907-8 · Cited by 32
Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R
Br�ckner, G., Grosche, J., Schmidt, S., H�rtig, W., Margolis, R. U., Delpech, B., Seidenbecher, C. I., Czaniera, R., & Schachner, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001225)428:4<616::aid-cne3>3.0.co;2-k
Self-citation
Metadata
- Authors
- Milev, P., Chiba, A., Häring, M., Rauvala, H., Schachner, M., Ranscht, B., Margolis, R. K., & Margolis, R. U.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-03
- Volume
- 273
- Issue
- 12
- Pages
- 6998-7005
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1968365109
- Cited by
- 190
- References
- 2
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 8261 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.